ARBOR BIOTECHNOLOGIES
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
ARBOR BIOTECHNOLOGIES
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.arbor.bio
Total Employee:
51+
Status:
Active
Contact:
857 301 6366
Email Addresses:
[email protected]
Total Funding:
230.6 M USD
Technology used in webpage:
Google Font API Google Maps Amazon Google Google Cloud U.S. Server Location Google Maps API Amazon Virginia Region Amazon SSL Google Maps For Work
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Benchling
Benchling is a cloud-based software platform for biology researchers and research and development organizations.
Calibre Scientific
Calibre is a diversified global developer, manufacturer and distributor of consumable products in the life sciences and diagnostics markets.
Cambrian Biopharma
Cambrian is a distributed development company building therapeutics to lengthen health span.
Cartography Biosciences
Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest, most effective targets.
Ginkgo Bioworks
Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Nabla Bio
Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.
Resilience
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2024-05-08 | Serendipity Biosciences | Serendipity Biosciences acquired by Arbor Biotechnologies | N/A |
Investors List
TCG Crossover
TCG Crossover investment in Series B - Arbor Biotechnologies
ArrowMark Partners
ArrowMark Partners investment in Series B - Arbor Biotechnologies
Ally Bridge Group
Ally Bridge Group investment in Series B - Arbor Biotechnologies
Logos Capital
Logos Capital investment in Series B - Arbor Biotechnologies
Tao Capital Partners
Tao Capital Partners investment in Series B - Arbor Biotechnologies
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Arbor Biotechnologies
Tekla Capital Management
Tekla Capital Management investment in Series B - Arbor Biotechnologies
Surveyor Capital
Surveyor Capital investment in Series B - Arbor Biotechnologies
Deep Track Capital
Deep Track Capital investment in Series B - Arbor Biotechnologies
Vertex Pharmaceuticals
Vertex Pharmaceuticals investment in Series B - Arbor Biotechnologies
Key Employee Changes
Official Site Inspections
http://www.arbor.bio Semrush global rank: 2.75 M Semrush visits lastest month: 6.35 K
- Host name: vps105547.inmotionhosting.com
- IP address: 213.165.237.2
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Arbor Biotechnologies"
We Are - Arbor Biotechnologies®
Nov 11, 2022 Pam was brought into Editas to build the development organization, drive productive collaborations, and notably led the team that filed the first IND for an in vivo …See details»
Inside Arbor - Arbor Biotechnologies®
Nov 11, 2022 At Arbor, we make giving back part of the employee experience by matching employee donations, organizing volunteer opportunities year-round, facilitating a company …See details»
Arbor Biotechnologies - Crunchbase Company Profile …
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services. The company's platform …See details»
Arbor Biotechnologies 2025 Company Profile: …
Arbor Biotechnologies General Information Description. Developer of genomic tools designed to improve human health and sustainability. The company's …See details»
Arbor Biotechnologies: Revenue, Worth, Valuation & Competitors …
About Arbor Biotechnologies. Arbor Biotechnologies is a Biotech related company based in Cambridge with 181 employees an estimated revenue of $28.1M, and. It has 10 competitors …See details»
Arbor Biotechnologies Secures $105 Million in Series B Funding for ...
Jan 29, 2025 In an exciting development for the biotechnology landscape, Arbor Biotechnologies has successfully raised $105 million in its latest funding round. Arbor Bio is a pioneering force …See details»
Arbor Biotechnologies Appoints Industry Veteran R. Nolan …
CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, …See details»
Get In Touch - Arbor Biotechnologies™
You are about to leave Arbor.bio. Please click “OK” if you wish to be taken to a site to get more information. Cancel OK. × We are using cookies to give you the best experience on our website. You can find out more about which cookies …See details»
Arbor Biotechnologies - MassBio
Arbor Biotechnologies is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines. Founded by Feng Zhang, David Walt, …See details»
Arbor Biotechnologies - Funding, Financials, Valuation …
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services. New. ... Arbor Biotechnologies has acquired Serendipity Biosciences on May 8, 2024. ... How much funding …See details»
Arbor Biotechnologies, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Arbor Biotechnologies, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 50 news, and 10 literature, Disease Domain:Endocrinology and Metabolic …See details»
Company: Arbor Biotechnologies - CRISPR Medicine
Arbor Biotechnologies is a CRISPR-focused company that develops novel Cas variants for enhanced precision and efficacy. The company's lead programme is being developed for …See details»
Next-Generation Gene Editing - Arbor Biotechnologies™
Addressing the biology driving disease is complicated, and we believe that each disease requires a unique approach. Application of our platform is goal-driven to find the right tool for each …See details»
Arbor Biotechnologies - Work in biotech
Arbor Biotechnologies is developing genetic medicines to treat genetic diseases.To treat a genetic disease, the underlying genetic pathology must first be understood. With this knowledge, Arbor …See details»
Arbor raises $74M amid genetic medicine’s funding slump
Mar 18, 2025 Arbor’s funding comes during a tough stretch for gene and cell therapy developers. Private funding has slowed down since the sector’s peak as investors have flocked towards …See details»
Arbor Biotechnologies Announces $73.9 Million Series C
Mar 18, 2025 Arbor Biotechnologies™, a next-generation gene editing company based in Cambridge, MA, is advancing a pipeline of novel gene editing therapeutics to address a wide …See details»
Press Releases - Arbor Biotechnologies™
Dec 19, 2024 Arbor Biotechnologies ®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief Executive Officer, …See details»
BIO Releases New Report Underscoring the Massive Economic …
2 days ago WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind …See details»
Arbor Biotechnologies Announces $73.9 Million Series C Financing …
Mar 18, 2025 With Arbor’s lead program, ABO-101 for the treatment of primary hyperoxaluria type 1, in clinical development, the company continues to focus their research and …See details»
Our Pipeline - Arbor Biotechnologies®
Arbor; Liver: ABO-101. PH1 (HAO1) Knockdown+. LNP. ABO-101 - PH1 (HAO1) Tech: Knockdown+ Delivery: LNP Status: Disc. Lead Opt. IND Clinical; ABO-103. Undisclosed. ...See details»